NJ Endovascular and Amputation Prevention, LLP — Clifton, New Jersey

NJ Endovascular and Amputation Prevention, LLP is a clinical research site located in Clifton, New Jersey, United States 07013.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

NJ Endovascular and Amputation Prevention, LLP has participated in 1 clinical trials.

Therapeutic areas: Peripheral Arterial Disease.

Sponsors: Veryan Medical Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Clifton

Browse all research sites in New Jersey · View every site in Clifton

• New Jersey Physicians
• GSK Investigational Site
• Research Site
• REAL Prevention LLC
• Clifton-Wallington Medical Group
• NJP Clinical Research
• 228
• Care Access - Clifton
• Summit Medical Group
• Pfizer Investigational Site
• Forest Investigative Site 036
• Gastroenterology Associates of New Jersey, LLC

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NJ Endovascular and Amputation Prevention, LLP?

NJ Endovascular and Amputation Prevention, LLP has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NJ Endovascular and Amputation Prevention, LLP conducted?

NJ Endovascular and Amputation Prevention, LLP has 1 clinical trials on record. Their work covers Peripheral Arterial Disease.

Is NJ Endovascular and Amputation Prevention, LLP accredited by Crixeo Clinical Trials?

NJ Endovascular and Amputation Prevention, LLP has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NJ Endovascular and Amputation Prevention, LLP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.